Table of Contents:

1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS
1.1.1 GLOBAL PROBIOTICS MARKET, BY TYPE
1.1.2 GLOBAL PREBIOTICS MARKET, BY APPLICATION
1.1.3 GLOBAL PROBIOTICS MARKET, BY REGION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 KEY BUYING CRITERIA
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 FORECAST MODEL
3.6 LIST OF ASSUMPTIONS
4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 INCREASING EMPHASIS ON IMPROVING DIGESTIVE HEALTH IN HUMANS AND ANIMALS
5.2.2 SURGING DEMAND FOR NATURAL FUNCTIONAL INGREDIENTS IN APPLICATION INDUSTRIES
5.2.3 DRIVERS IMPACT ANALYSIS
5.3 RESTRAINT
5.3.1 REGULATORY CONSTRAINTS
5.3.2 RESTRAINTS IMPACT ANALYSIS
5.4 OPPORTUNITIES
5.4.1 PRODUCT INNOVATION
6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS
6.1.1 RAW MATERIAL PROCUREMENT
6.1.2 PROCESSING
6.1.3 PACKAGING
6.2 SUPPLY CHAIN ANALYSIS
6.3 PORTER'S FIVE FORCES MODEL
6.3.1 THREAT OF NEW ENTRANTS
6.3.2 BARGAINING POWER OF SUPPLIERS
6.3.3 BARGAINING POWER OF BUYERS
6.3.4 THREAT OF SUBSTITUTES
6.3.5 INTENSITY OF RIVALRY
7 GLOBAL PROBIOTICS MARKET, BY TYPE
7.1 OVERVIEW
7.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY TYPE, 2014-2025
7.2 BIFIDOBACTERIUM
7.2.1 BIFIDOBACTERIUM: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
7.3 LACTOBACILLUS
7.3.1 LACTOBACILLUS: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
7.4 OTHERS
7.4.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
8 GLOBAL PROBIOTICS MARKET, BY APPLICATION
8.1 OVERVIEW
8.1.1 GLOBAL PROBIOTICS MARKET ESTIMATES & FORECAST, BY APPLICATION, 2014-2025
8.2 FUNCTIONAL FOOD & BEVERAGES
8.2.1 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
8.3 DIETARY SUPPLEMENTS
8.3.1 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
8.4 ANIMAL NUTRITION
8.4.1 ANIMAL NUTRITION: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
8.5 OTHERS
8.5.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2014-2025
9 GLOBAL PROBIOTICS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 SPAIN
9.3.5 ITALY
9.3.6 RUSSIA
9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 VIETNAM
9.4.6 SOUTH KOREA
9.4.7 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 ARGENTINA
9.5.3 COLOMBIA
9.5.4 CHILE
9.5.5 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SAUDI ARABIA
9.6.2 UAE
9.6.3 EGYPT
9.6.4 NIGERIA
9.6.5 SOUTH AFRICA
9.6.6 REST OF MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 COMPETITIVE BENCHMARKING
10.3 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.3.1 PRODUCT LAUNCHES/SERVICE DEPLOYMENTS
10.3.2 MERGERS & ACQUISITIONS
10.3.3 JOINT VENTURES
10.3.4 EXPANSION
11 COMPANY PROFILES
11.1 CHR. HANSEN A/S
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NOVOZYMES A/S
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 LALLEMAND INC.
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 PROBI AB
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 KERRY GROUP PLC
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 SABINSA CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 DOWDUPONT INC.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 SYNBIO TECH INC.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 ROELMI HPC
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENT
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.1 UAS LABORATORIES LLC
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
11.11 PROBIOTICAL SPA
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 SWOT ANALYSIS
11.11.6 KEY STRATEGIES
11.12 GREENTECH SA
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 SWOT ANALYSIS
11.12.6 KEY STRATEGIES
11.13 BIOSEARCH, SA
11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL OVERVIEW
11.13.3 PRODUCTS OFFERED
11.13.4 KEY DEVELOPMENTS
11.13.5 SWOT ANALYSIS
11.13.6 KEY STRATEGIES
11.14 BIOCC Ou
11.14.1 COMPANY OVERVIEW
11.14.2 FINANCIAL OVERVIEW
11.14.3 PRODUCTS OFFERED
11.14.4 KEY DEVELOPMENTS
11.14.5 BIOCC Ou PATENTS: PROBITOTICS MARKET
11.14.6 SWOT ANALYSIS
11.14.7 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES